Related Experiment Video
Updated: Nov 17, 2025
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.7K
CSF proteome in multiple sclerosis subtypes related to brain lesion transcriptomes.
Maria L Elkjaer1,2,3, Arkadiusz Nawrocki4, Tim Kacprowski5,6
1Department of Neurology, Odense University Hospital, J.B. Winslowsvej 4, 5000, Odense C, Denmark.
Scientific Reports
|February 19, 2021
Summary
Researchers identified 8 key proteins in cerebrospinal fluid (CSF) that differentiate multiple sclerosis (MS) subtypes, with secondary progressive MS showing unique alterations. This CSF profile and brain lesion analysis reveal non-inflammatory mechanisms in CNS diseases.
Area of Science:
- Neuroscience
- Proteomics
- Biochemistry
Background:
- Multiple Sclerosis (MS) comprises various subtypes with distinct clinical and pathological features.
- Cerebrospinal fluid (CSF) and brain lesions are crucial for understanding CNS disease mechanisms.
- Identifying subtype-specific biomarkers is essential for accurate diagnosis and targeted therapies.
Purpose of the Study:
- To discover novel protein markers in CSF that distinguish between different subtypes of MS.
- To correlate CSF proteomic findings with gene expression patterns in MS brain lesions.
- To elucidate non-inflammatory mechanisms underlying CNS disease and MS subtype differentiation.
Main Methods:
- A two-step proteomic approach was employed, starting with discovery proteomics on pooled CSF samples.
- Comprehensive statistical analysis identified 299 candidate proteins quantified in individual CSF samples.
- Gene expression analysis of identified proteins was performed on MS brain lesions and control brain tissues.
Main Results:
- Eight proteins were identified as differentiating MS subtypes, with secondary progressive MS (SPMS) exhibiting the most significant differences.
- Genes of seven of these proteins were found in MS brain lesions, with specific genes differentially expressed in various lesion types.
- Volcano maps indicated the highest number of altered proteins in SPMS, suggesting its unique pathological profile.
Conclusions:
- The identified CSF proteomic profile, alongside brain lesion data, highlights non-inflammatory mechanisms in differentiating CNS diseases and MS subtypes.
- The unique protein signature in SPMS underscores its distinctiveness among MS subtypes.
- This research provides potential biomarkers for MS subtyping and offers insights into disease pathogenesis.
